Skip to main content
Fig. 5 | Malaria Journal

Fig. 5

From: Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas

Fig. 5

Prevalence of individuals with IgG, IgM, IgA and IgE antibodies against GLURP, MSP-3, and Pfs48/45. 1P < 0.0001, CZS IgE GLURP versus ML and GJ IgE GLURP. 2P = 0.001, CZS IgG MSP-3 versus ML IgG MSP-3, P = 0.0003, CZS IgG MSP-3 versus GJ IgG MSP-3. 3P < 0.0001, CZS IgM MSP-3 versus GJ IgM MSP-3. 4P = 0.04, CZS IgG Pfs48/45 versus ML IgG Pfs48/45. 5P = 0.02, CZS IgE Pfs48/45 versus GJ IgE Pfs48/45. Prevalence of responders within and between groups were compared by Chi-squared tests

Back to article page